This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gil, M. Articles by Pérez, G. Search for Related Content PubMed PubMed Citation Articles by Gil, M. Articles by Pérez, G. Pubmed/NCBI databases Medline Plus Health Information Heart Attack Related Collections Cardiovascular Pharmacology Acute myocardial infarction

(Circulation. 1999;99:1767-1773.)
© 1999 American Heart Association, Inc.

Current Perspective

Relationship of Therapeutic Improvements and 28-Day Case Fatality in Patients Hospitalized With Acute Myocardial Infarction Between 1978 and 1993 in the REGICOR Study, Gerona, Spain

M. Gil, MD; J. Marrugat, MD; J. Sala, MD; R. Masiá, MD; R. Elosua, MD; X. Albert, MD; A. Pena, MD; J. Vila, PhD; M. Pavesi, PhD; G. Pérez, MD; for the REGICOR Investigators

From the Lipids and Cardiovascular Epidemiology Unit, Institut Municipal d'Investigació Mèdica, Barcelona, Spain (M.G., J.M., R.E., A.P., J.V., M.P., G.P.), and Servei de Cardiologia, Hospital Universitari de Girona "Dr Josep Trueta," Gerona, Spain (J.S., R.M., X.A.).

Correspondence to Dr Jaume Marrugat, Unitat de Lipids i Epidemiologia Cardiovascular, Institut Municipal d'Investigació Mèdica, Carrer Dr Aiguader 80, 08003 Barcelona, Spain. E-mail JAUME{at}IMIM.ES

Background—The aim of this study was to analyze 28-day case fatality trends between 1978 and 1993 among hospitalized acute myocardial infarction (AMI) patients in the REGICOR registry, Gerona, Spain, and relate them to thrombolytic and antiplatelet drug use and changes in patient characteristics.

Methods and Results—A total of 2053 consecutive patients 25 to 74 years of age with a first Q-wave AMI admitted to the reference hospital between 1978 and 1993 were registered. Clinical characteristics and patient management were recorded. Four 4-year periods were considered: 1978 to 1981, 1982 to 1985 (prethrombolytic therapy), 1986 to 1989 (thrombolytic and antiplatelet drugs introduced), and 1990 to 1993 (thrombolytic and antiplatelet drugs used routinely). The end point was death at 28 days. Case fatality at 28 days decreased 6% per year between 1978 and 1993. A logistic model adjusted for comorbidity and severity showed the last 3 periods to present a steep decrease in the OR of death at 28 days: 0.86 (95% CI, 0.52 to 1.41), 0.59 (95% CI, 0.35 to 0.99), and 0.40 (95% CI, 0.24 to 0.69), respectively, compared with the first period. After 1986, 85.7% of the 112 lives saved could be attributed to the use of antiplatelet and thrombolytic drugs. Adjusted relative risk reduction was 56.0% for antiplatelet drugs, 34.1% for thrombolytic drugs, and 77.9% for the 2 combined.

Conclusions—Our results strongly suggest that new therapies introduced since 1986 have contributed to the decrease in 28-day case fatality of patients admitted with a first Q-wave AMI. This decrease could be attributable mainly to the use of antiplatelet and thrombolytic drugs. These findings should encourage the routine use of thrombolytic and antiplatelet drugs and particularly their combination in the acute phase of AMI.

Key Words: myocardial infarction • mortality • platelet aggregation inhibitors • thrombolysis

This article has been cited by other articles:

				J Sala, R Masia, F-J Gonzalez de Molina, J M Fernandez-Real, M Gil, D Bosch, W Ricart, M Senti, and J Marrugat Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission J Epidemiol Community Health, September 1, 2002; 56(9): 707 - 712. [Abstract] [Full Text] [PDF]

				J Marrugat, M Gil, R Masia, J Sala, R Elosua, J M Anto, and the REGICOR Investigators Role of age and sex in short-term and long term mortality after a first Q wave myocardial infarction J Epidemiol Community Health, July 1, 2001; 55(7): 487 - 493. [Abstract] [Full Text] [PDF]

				M. I. Furman, H. L. Dauerman, R. J. Goldberg, J. Yarzbeski, D. Lessard, and J. M. Gore Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial q-wave and non-q-wave myocardial infarction: a multi-hospital, community-wide perspective J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1571 - 1580. [Abstract] [Full Text] [PDF]

				R. Zahn, R. Schiele, S. Schneider, A. K. Gitt, H. Wienbergen, K. Seidl, C. Bossaller, H. J. Buttner, M. Gottwik, E. Altmann, et al. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis: Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR) J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2064 - 2071. [Abstract] [Full Text] [PDF]

				A. Brodison, R. S More, and A. Chauhan Stents in medicine: The role of coronary angioplasty and stenting in acute myocardial infarction Postgrad. Med. J., October 1, 1999; 75(888): 591 - 598. [Abstract] [Full Text]